GlassScriptPhysician profile
Sandeep Sehgal
NPI 1326066218
$22,434.66
in general payments reported to CMS, 2019-2025
29 companies · $2,269 in 2025
The $2,269 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,726 · 2020: $3,234 · 2021: $4,128 · 2022: $5,459 · 2023: $2,074 · 2024: $1,545 · 2025: $2,269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,793 · Grant: $95.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,793.02 |
| Grant | $95.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $3,646.55 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Edwards Lifesciences Corporation | $3,632.99 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Pascal |
| Boston Scientific Corporation | $3,030.11 | 2019-2025 | Watchman Access System, Watchman Flx, General - Structural Heart |
| Bard Peripheral Vascular, INC. | $2,955.62 | 2020-2025 | Rotarexs 6 F X 135 Cm |
| Penumbra, INC. | $2,629.25 | 2019-2023 | Penumbra System |
| Abiomed | $1,939.64 | 2019-2025 | Impella |
| Medtronic, INC. | $1,309.26 | 2021-2024 | Corevalve Evolut R |
| Shockwave Medical, INC | $769.00 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| W. L. Gore & Associates, INC. | $317.83 | 2019 | |
| Abbott Laboratories | $315.60 | 2020-2025 | Coroflow, Perclose Prostyle, Cardiomems |
| Novartis Pharmaceuticals Corporation | $309.73 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $279.68 | 2019-2022 | |
| Medtronic Vascular, INC. | $269.53 | 2019-2020 | |
| Terumo Medical Corporation | $173.80 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $134.05 | 2019-2023 | Lifevest |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $125.00 | 2025 | Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $110.00 | 2019 | |
| Astellas Pharma US INC | $105.12 | 2023-2024 | Veozah, Myrbetriq |
| Biosense Webster, INC. | $76.63 | 2025 | Nuvision Ice Catheter |
| Becton, Dickinson and Company | $70.91 | 2025 | Rotarexs 6 F X 135 Cm |
| Pfizer INC. | $51.39 | 2021-2024 | |
| Cardiovascular Systems INC. | $35.77 | 2022 | |
| Angiodynamics, INC. | $35.36 | 2023-2024 | Angiovac, Alphavac |
| Stryker Corporation | $32.80 | 2025 | Artix Mt |
| Axsome Therapeutics, INC. | $27.10 | 2024 | Auvelity |
| Esperion Therapeutics, INC. | $26.82 | 2021 | |
| Gilead Sciences, INC. | $13.59 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.53 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandeep Sehgal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.